Please login to the form below

Not currently logged in


This page shows the latest NHS news and features for those working in and with pharma, biotech and healthcare.

NICE says no to rival Alnylam and Akcea amyliodsis drugs – but deal could be done

NICE says no to rival Alnylam and Akcea amyliodsis drugs – but deal could be done

Our focus now will be on addressing the immediate questions posed by the Committee and on working towards securing a positive, sustainable agreement that represents value for the NHS and that

Latest news

More from news
Approximately 287 fully matching, plus 1,607 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 28 fully matching, plus 131 partially matching documents found.

Latest appointments

More from appointments
Approximately 18 fully matching, plus 82 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 25 fully matching, plus 172 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...